Bethesda, Maryland 20892

  • Sexuality and Reproductive Issues

Purpose:

RATIONALE: Gathering information from women who are BRCA1 or BRCA2 mutation carriers may help doctors learn how they manage cancer risk and meet the challenges of young adulthood. PURPOSE: This clinical trial is studying the impact of testing positive for the BRCA1/2 mutation in young women who are BRCA1 or BRCA2 mutation carriers.


Study summary:

OBJECTIVES: - Recruit 30-50 BRCA1/2-positive women aged 18-35 to participate in a semi-structured, qualitative methods interview study. - Facilitate focus group including additional mutation-positive women (n = 25-50) to provide feedback regarding results and analyses. - Increase knowledge of young women's experiences in navigating the tasks and challenges of young adulthood, within the context of their experiences as BRCA1/2 mutation carriers, including family history, genetic testing, couple relationships, family formation, and cancer risk management. - Verify new information via focus groups with other mutation-positive individuals. - Disseminate new knowledge via professional presentations and publications. OUTLINE: Participants undergo telephone interviews for approximately 90 minutes, comprising open-ended questions about demographic information and personal history of cancer; four questions about the history of cancer in their families; experiences with genetic testing; couple relationships, including experiences with disclosure of positive mutation status to past, current, and/or future partners; nexus of experiences as mutation-positive and their plans regarding family creation; and questions regarding the use of cancer risk-management and risk-reducing strategies for qualitative analysis of couple and family treatment strategies. Participants also undergo focus group sessions in-person at the Joining FORCEs conference.


Criteria:

DISEASE CHARACTERISTICS: - Completed genetic testing and received a positive test result (i.e., a deleterious or disease-related mutation identified) for BRCA1 or BRCA2 - Experienced or contemplating/planning couple relationship(s), formation of a family, and/or risk management/reduction strategies - Meets ≥ 1 of the following criteria: - Attended the Joining FORCEs 2009 Annual Conference in May 2009 (focus groups) - Previously participated in the Clinical Genetics Branch of NCI Breast Imaging or Hereditary Breast/Ovarian Cancer studies PATIENT CHARACTERISTICS: - Able to speak and understand English with a level of fluency sufficient for completion of a recorded telephone interview - Willing to have interview digitally recorded PRIOR CONCURRENT THERAPY: - Not specified


NCT ID:

NCT00954239


Primary Contact:

Principal Investigator
Mark H. Greene, MD
Clinical Genetics Branch


Backup Contact:

N/A


Location Contact:

Bethesda, Maryland 20892
United States

Clinical Trials Office - Warren Grant Magnusen Clinical Center
Phone: 888-NCI-1937

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 27, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.